These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33744228)

  • 1. High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited setting.
    Maryam DU; Mukhtar IG; Yusuf AA; Salisu AI
    Hematol Transfus Cell Ther; 2022; 44(3):386-391. PubMed ID: 33744228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and characterization of RHD variant alleles in a population of blood donors from southeastern Brazil: Comparison with other populations.
    Rodrigues ES; Romagnoli AC; Santos FLS; Cutter TB; Catelli LF; Cédric V; Peyrard T; Covas DT; de Castilho LM; Kashima S
    Transfus Apher Sci; 2021 Aug; 60(4):103135. PubMed ID: 33867285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.
    Sandler SG; Chen LN; Flegel WA
    Br J Haematol; 2017 Oct; 179(1):10-19. PubMed ID: 28508413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHD genotyping of serological weak D phenotypes in the Iranian blood donors and patients.
    Oodi A; Daneshvar Z; Goudarzi S; Amirizadeh N
    Transfus Apher Sci; 2020 Oct; 59(5):102870. PubMed ID: 32660892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
    Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological and molecular characterisation of the most prevalent weak D variants in Croatian population.
    Stanic HS; Galic ZK; Dogic V; Bingulac-Popovic J; Jukic I
    Transfus Med; 2023 Apr; 33(2):132-136. PubMed ID: 36453092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations - Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-antigen.
    Chun S; Kim H; Yun JW; Yu H; Seo JY; Cho D
    Transfus Apher Sci; 2020 Aug; 59(4):102807. PubMed ID: 32423605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.
    McGowan EC; Lopez GH; Knauth CM; Liew YW; Condon JA; Ramadi L; Parsons K; Turner EM; Flower RL; Hyland CA
    Vox Sang; 2017 Apr; 112(3):279-287. PubMed ID: 28220510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype analysis to clarify RhD variants in discrepant samples of Chilean population.
    Aburto A; Zapata D; Retamales E; Fernández J; Barra G; Peña F; Cárcamo S; Saavedra N; Sandoval C; Orellana J; Caamaño J
    Front Immunol; 2023; 14():1299639. PubMed ID: 38116010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characteristics of the Serological Weak D Phenotype in Koreans.
    Jeong D; Oh S; Song EY; Hong YJ; Park KU
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34063775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterisation of RhD variants in North Indian blood donor population.
    Khetan D; Verma A; Chaudhary RK; Shukla JS
    Transfus Med; 2020 Aug; 30(4):295-303. PubMed ID: 32488899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the serological underrecognition of patients with weak or partial RHD variants.
    Ramsey G; Barriteau CM
    Transfusion; 2024 May; 64(5):920-928. PubMed ID: 38634174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes.
    Cruz BR; Chiba AK; Moritz E; Bordin JO
    Transfus Med; 2012 Apr; 22(2):84-9. PubMed ID: 22211984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D variants in the population of D-negative blood donors in the north-eastern region of Croatia.
    Safic Stanic H; Dogic V; Herceg I; Jagnjic S; Bingulac-Popovic J; Babic I; Corusic A; Jukic I
    Transfus Med; 2021 Feb; 31(1):43-47. PubMed ID: 33034130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RHD(T201R, F223V) cluster analysis in five different ethnic groups and serologic characterization of a new Ethiopian variant DARE, the DIII type 6, and the RHD(F223V).
    Grootkerk-Tax MG; van Wintershoven JD; Ligthart PC; van Rhenen DJ; van der Schoot CE; Maaskant-van Wijk PA
    Transfusion; 2006 Apr; 46(4):606-15. PubMed ID: 16584437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance and costs of RHD genotyping in women with a weak D phenotype.
    Laget L; Izard C; Durieux-Roussel E; Gouvitsos J; Dettori I; Chiaroni J; Ferrera-Tourenc V
    Transfus Clin Biol; 2019 Feb; 26(1):27-31. PubMed ID: 29866395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RHD genotyping to resolve weak and discrepant RhD patient phenotypes.
    Barriteau CM; Lindholm PF; Hartman K; Sumugod RD; Ramsey G
    Transfusion; 2022 Nov; 62(11):2194-2199. PubMed ID: 36218305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.
    Wang QP; Dong GT; Wang XD; Gu J; Li Z; Sun AY; Shao CP; Pan ZL; Huang LH; Xie WX; Sun GM; Chen JJ; Pei H; Yang XJ; Shan PN
    Blood Transfus; 2014 Apr; 12(2):238-43. PubMed ID: 23399369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists.
    Sandler SG; Roseff SD; Domen RE; Shaz B; Gottschall JL
    Arch Pathol Lab Med; 2014 May; 138(5):620-5. PubMed ID: 24786120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.
    Lukacevic Krstic J; Dajak S; Bingulac-Popovic J; Dogic V; Mratinovic-Mikulandra J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28649781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.